Author: The INO.com Team

Traders WhiteBoard Lesson 4

Posted on by The INO.com Team

Hello traders everywhere! Adam Hewison here, co-founder of MarketClub with Traders WhiteBoard Lesson 4.

Today’s lesson is perhaps one of the most important lessons we have in the Traders WhiteBoard series. I will share with you important information about stops and money management, so you can be successful in any market.

Loading the player...

This is the one lesson you do not want to skip. Lesson 4 provides you with the structure you will need to build and grow your bottom line in the future.

Today’s video runs a little over four minutes in length. My personal goal is that you find this lesson helpful, informative, and above all educational.

Every Success,
Adam Hewison
President, INO.com
Co-Creator, MarketClub

Today's Video Update: Syria Shakes The Market

Posted on by The INO.com Team

Hello traders everywhere! Adam Hewison here, President of INO.com and Co-creator of MarketClub, with your mid-day market update for Tuesday, the 27th of August.

Syria Shakes The Market
Reading the news this morning, I see that we're going to strike Syria with cruise missiles and bombs as early as Thursday. How nice of us to announce what we are going to do in advance. No one knows what is going to happen when and if these events occur. All we can go on is the collective judgment of the market.

Bill Ackman Surrenders
Bill Ackman finally surrenders and shows how you can lose $500 million on a trade. In my humble opinion, activist investors should not be getting into old-style retail marketing stores like JC Penney (NYSE:JCP). Continue reading "Today's Video Update: Syria Shakes The Market" →

Today's Video Update: Amgen moves into the big business of cancer drugs

Posted on by The INO.com Team

Hello traders everywhere! Adam Hewison here, President of INO.com and Co-creator of MarketClub, with your mid-day market update for Monday, the 26th of August.

The big news today is that Amgen (NASDAQ:AMGN) has agreed to buy Onyx Pharmaceuticals (NASDAQ:ONXX) for $10.4 billion. Amgen, the world's biggest biotechnology company, was missing from one of the biggest and fastest growing markets, cancer drugs. With the acquisition of Onyx Pharmaceuticals, Amgen will gain access to the company's three anticancer treatments. I will be analyzing Amgen today using our Trade Triangle technology and will share with you the trading results for the year so far. Continue reading "Today's Video Update: Amgen moves into the big business of cancer drugs" →